<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>the Generic Medicines community of South Africa</title><link>http://medical.bizcommunity.com//196/318.html</link><description>South Africa Generic Medicines news</description><ttl>15</ttl><category>Generic Medicines news - South Africa</category><image><url>http://www.bizcommunity.com/res/img/11/logo5.gif</url><title>Bizcommunity.com</title><link>http://www.bizcommunity.com/</link></image><language>en-us</language><pubDate>Fri, 05 Sep 2008 18:34:30 +0200</pubDate><item><title>Health experts discuss counterfeit medicine</title><link>http://www.bizcommunity.com/Article/196/148/21965.html</link><description>An international conference discussing threats of counterfeit medicine and their effects on patients in Africa is underway in Johannesburg. &lt;a href="http://www.bizcommunity.com/Article/196/148/21965.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=148&amp;ct=1&amp;ci=21965"&gt;Send to a friend&lt;/a&gt;&lt;br clear="left" /&gt;</description><guid>http://www.bizcommunity.com/Article/196/148/21965.html</guid><pubDate>Thu, 14 Feb 2008 06:26:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/318.html</source></item><item><title>Industry news: Sandoz uses ongoing X/Procure® system to promote products</title><link>http://www.bizcommunity.com/Article/196/318/17841.html</link><description>X/procure®, the advertising procurement system directly targeting pharmacists has launched a campaign for Sandoz, one of the world's leading generic pharmaceutical companies. The ongoing campaign has seen four new central nervous system (CNS) products launch into more than 1500 pharmacies countrywide. &lt;a href="http://www.bizcommunity.com/Article/196/318/17841.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=318&amp;ct=1&amp;ci=17841"&gt;Send to a friend&lt;/a&gt;&lt;br clear="left" /&gt;</description><guid>http://www.bizcommunity.com/Article/196/318/17841.html</guid><pubDate>Thu, 06 Sep 2007 12:27:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/318.html</source></item><item><title>Industry news: Pfizer breaks into generics</title><link>http://www.bizcommunity.com/Article/196/318/17431.html</link><description>To enhance the quality of life of more people in South Africa, Pfizer SA recently launched Pharmacia, focusing exclusively on the provision of original generic medicines to specifically address some of the country's critical disease areas. &lt;a href="http://www.bizcommunity.com/Article/196/318/17431.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=318&amp;ct=1&amp;ci=17431"&gt;Send to a friend&lt;/a&gt;&lt;br clear="left" /&gt;</description><guid>http://www.bizcommunity.com/Article/196/318/17431.html</guid><pubDate>Thu, 23 Aug 2007 15:56:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/318.html</source></item><item><title>FDA tells drug giant to come clean about Alzheimer's drug</title><link>http://www.bizcommunity.com/Article/196/318/17194.html</link><description>The Food and Drug Administration (FDA) in the U.S. has warned a major drug company about misleading the medical profession over a drug for dementia. &lt;a href="http://www.bizcommunity.com/Article/196/318/17194.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=318&amp;ct=1&amp;ci=17194"&gt;Send to a friend&lt;/a&gt;&lt;br clear="left" /&gt;</description><guid>http://www.bizcommunity.com/Article/196/318/17194.html</guid><pubDate>Thu, 16 Aug 2007 10:24:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/318.html</source></item><item><title>Novartis ruling good news for ARV access</title><link>http://www.bizcommunity.com/Article/196/149/17090.html</link><description>News of the Indian High Court's ruling against Swiss pharmaceutical giant, Novartis, this week, has been welcomed by AIDS activists in the developing world. &lt;a href="http://www.bizcommunity.com/Article/196/149/17090.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=149&amp;ct=1&amp;ci=17090"&gt;Send to a friend&lt;/a&gt;&lt;br clear="left" /&gt;</description><guid>http://www.bizcommunity.com/Article/196/149/17090.html</guid><pubDate>Tue, 14 Aug 2007 08:40:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/318.html</source></item><item><title>Industry news: Indoor media promoting Cipla Medpro</title><link>http://www.bizcommunity.com/Article/196/318/16226.html</link><description>Cipla Medpro has teamed up with The Letter Corporation (TLC) to promote Cipla's generic consumer and prescription medicines in selected Netcare Hospitals. &lt;a href="http://www.bizcommunity.com/Article/196/318/16226.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=318&amp;ct=1&amp;ci=16226"&gt;Send to a friend&lt;/a&gt;&lt;br clear="left" /&gt;</description><guid>http://www.bizcommunity.com/Article/196/318/16226.html</guid><pubDate>Mon, 16 Jul 2007 09:45:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/318.html</source></item><item><title>Industry news: Thebe Pharmaceuticals focuses on the supply of cost effective treatment</title><link>http://www.bizcommunity.com/Article/196/148/15831.html</link><description>Thebe Pharmaceuticals, local black-empowered healthcare group with its focus on the supply of cost effective pharmaceuticals, has tasked X/procure® to drive awareness of its probiotic product Reuteri, directly to pharmacists. &lt;a href="http://www.bizcommunity.com/Article/196/148/15831.html"&gt;Read full story...&lt;/a&gt; | &lt;a href="http://www.bizcommunity.com/SendToFriend.aspx?l=196&amp;c=148&amp;ct=1&amp;ci=15831"&gt;Send to a friend&lt;/a&gt;&lt;br clear="left" /&gt;</description><guid>http://www.bizcommunity.com/Article/196/148/15831.html</guid><pubDate>Fri, 29 Jun 2007 11:44:00 +0200</pubDate><source>http://www.bizcommunity.com/rss/196/318.html</source></item></channel></rss>